Navigation Links
MaxCyte Presents a Panel Discussion With Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery - LIVE Q&A to Follow
Date:12/15/2008

GAITHERSBURG, Md., Dec. 15 /PRNewswire/ --MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, announces that, due to popular demand, it will be rebroadcasting its webinar with industry experts on the challenges in developing cell-based screening assays for drug discovery. The broadcast is open to the industry and will be held by webinar on Tuesday December 16th at two convenient times, 9:00 AM and 7:30 PM EST. A live Q&A will follow the broadcast.

One of the respected industry experts who led the discussion was Dr. John Reardon, formerly Senior Vice President of Discovery Research Biology at Glaxo Smith Kline and now Executive Vice President and Chief Scientific Officer at Integrated Oncology Solutions Inc. (IOS) in North Carolina. Dr. Reardon reviewed the complexities of cell transfection technologies and challenged the webinar participants to consider the possibilities of creating more relevant assays if it were possible to transfect any molecule into any cell at any scale, while maintaining biological integrity and high quality standards. His discussion offered compelling arguments as to how the MaxCyte(R) STX System can reduce bottlenecks and improve the productivity of drug discovery groups.

Dr. James Brady, Director of Technical Applications at MaxCyte, led the webinar participants through a technical presentation of the MaxCyte(R) STX(TM) Scalable Transfection System. Dr. Brady demonstrated how the MaxCyte STX technology enables the large scale transfection of primary cells, cell lines, and stem cells with single and multiple loading agents at the same time, resulting in more relevant screening systems.

According to MaxCyte CEO Doug Doerfler, "We were delighted with the response to our previous webinar on the MaxCyte STX technology and the interest in continuing with the live panel discussion. The MaxCyte STX is being viewed by the pharmaceutical industry a
'/>"/>

SOURCE MaxCyte, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology
2. MaxCyte to Present at the BIO CEO & Investor Conference
3. MaxCyte to Present at the Phacilitate Cell and Gene Therapy Forum 2008
4. Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
5. Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis
6. CVS Caremark Presents Influenza Vaccine Data at Rescheduled 2008 DMAA Annual Meeting
7. Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile
8. Sonic Innovations Presents Donation to the Armed Forces Foundation
9. HMS Presents 4th Annual Heroes of Healthcare Awards
10. HealthEdge(R) Presents Award-Winning HealthRules(R) Technology Platform at the 2008 Gartner Healthcare Summit
11. Hearing Loss Presents a Significant Challenge for Rising Number of Caregivers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... from Montefiore Medical Center and the ... will present new findings at the Alzheimer,s Association International ... in Copenhagen, Denmark. Data from the four abstracts will ... normality to mild cognitive impairment and dementia. The research ... established in 1980 to examine healthy brain aging as ...
(Date:7/9/2014)... a reputation for being highly toxic, but when used in ... found to offer potential health benefits in a range of ... new compound (AP39), designed and made at the University of ... delivery of very small amounts of the substance to the ... Exeter have already found that the compound protects mitochondria ...
(Date:7/9/2014)... (July 9, 2014) A retrospective study conducted by ... colleagues reports that among adults with intellectual and developmental ... number of years receiving dental care increased. The findings, ... in Dentistry , may help improve interventions designed to ... , The researchers reviewed the dental records of ...
(Date:7/9/2014)... , , , , , ... , , , , ... SA80 assault rifle and the microphone is 50m downrange from the firer and approximately 30cm from the bullet... , ... , , , , , ... , , , , , ...
(Date:7/9/2014)... Medicine of the University of Southern California (USC) ... of the immune system are completely resistant to ... discovery suggests that blocking this immune system component ... hyper-inflammatory diseases such as rheumatoid arthritis and Type ... on June 23 in The Journal of ...
Breaking Medicine News(10 mins):Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7
... danger rises if the drugs are used with certain ... -- Antidepressant drugs called selective serotonin reuptake inhibitors (SSRIs), ... the risk of gastrointestinal bleeding, and the threat is ... and similar pain medications at the same time as ...
... Nurses Gain Stronger Voice for Patient Care, AUGUSTA, ... Center in Bangor, Maine appears to be over -- ... Registered nurses and hospital officials Thursday night reached ... the nurses say will,substantially enhance their voice in patient ...
... TO COMMENT ON THE MARKET FORECAST FOR THE DRUG, ... Ph.D., analyst,at Decision Resources, is available to discuss the ... of Merck,s Isentress, the,first integrase inhibitor drug which blocks ... new cells. Integrase inhibitors are a novel class ...
... New products, a growing world,population expected to reach ... the,aging of that population, will push anesthesia drug ... to Anesthesia Drugs: Worldwide Markets, a,new report by ... procedures required anesthetic,administration worldwide in 2006, and Kalorama ...
... Stryker Corporation,(NYSE: SYK ) disclosed today ... made an informal inquiry of the Company regarding ... connection with the sale,of medical devices in certain ... Securities and Exchange Commission regarding this,informal investigation. ...
... the 118 patients with portal vein thrombosis, noncirrhotic and ... with well tolerated bleed. Cirrhosis and tumor related portal ... Hypercoagulable state as a cause of portal vein thrombosis ... largest number of patients. , A research article to ...
Cached Medicine News:Health News:Antidepressants Boost GI Bleeding Risk 2Health News:MSNA: Strike Averted - Tentative Pact at EMMC 2Health News:Impending FDA Approval Decision on the First HIV Integrase Inhibitor Can Have Significant Impact for Patients 2Health News:Anesthesia Drugs Market to Grow to $4.3 Billion by 2011 as Populations and Uses for Anesthesia Increase 2Health News:Portal vein thrombosis is common in extraportal vein obstruction 2
(Date:1/15/2014)... 2014 Tegra Medical is very pleased to announce the ... new Chief Executive Officer.  Mark was promoted from his current ... the company,s four facilities in Massachusetts , ... joined Tegra Medical in 2012 with 20+ years of broad-based ...
(Date:1/15/2014)... The Cadence Fitness & Health Center has been ... Fitness Association, a non-profit organization assisting medically integrated health ... Cadence Fitness & Health Center is the only certified ... the Chicagoland area. "The certification means the ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... throughput reading of entire racks. Its scanner-based image ... and reads in approximately 10 seconds per rack. ... and a list of ActiveX controls is provided ... includes a USB HP Scanner and software. Compatible ...
... with powder-coated steel legs. Height ... in hundreds of sizes and ... light fixtures and ionizing equipment. ... custom building to meet special ...
Round, height-adjustable, steel laboratory stools with small footprint for small spaces • Choose options like different height-adjustment mechanism or paint finish. • your choice of color...
... This BioSafe room is configured specifically ... and chemical analysis. Panels are precision-joined ... easy to wipe down and disinfect. ... double-wall panel design creates strong, rigid ...
Medicine Products: